Unknown

Dataset Information

0

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.

ABSTRACT:

SUBMITTER: Tyc O 

PROVIDER: S-EPMC8462439 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.

Tyc Olaf O   Jansen Christian C   Schierwagen Robert R   Uschner Frank Erhard FE   Israelsen Mads M   Klein Sabine S   Ortiz Cristina C   Strassburg Christian P CP   Zeuzem Stefan S   Gu Wenyi W   Torres Sandra S   Praktiknjo Michael M   Kersting Stephan S   Langheinrich Melanie M   Nattermann Jacob J   Servant Florence F   Arumugam Manimozhiyan M   Krag Aleksander A   Lelouvier Benjamin B   Weismüller Tobias J TJ   Trebicka Jonel J  

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20201007 12

Similar Datasets

Unknown Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
| S-EPMC10244448 | biostudies-literature
Unknown Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.
| S-EPMC10222613 | biostudies-literature
Unknown Bile acid-mediated signaling in cholestatic liver diseases.
| S-EPMC10149012 | biostudies-literature
Unknown Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
| S-EPMC4780766 | biostudies-literature
Unknown The role of bile acids in cholestatic liver injury.
| S-EPMC8106037 | biostudies-literature
Unknown Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease.
| S-EPMC4810099 | biostudies-literature
Unknown Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids.
| S-EPMC4028388 | biostudies-literature
Unknown Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies.
| S-EPMC7214672 | biostudies-literature
Unknown Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
| S-EPMC4222180 | biostudies-literature
Unknown Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.
| S-EPMC7839474 | biostudies-literature